文献速递神经技术与安全MR

聚焦超声治疗后递送Gd标记IgG抗体至小鼠脑内

Delivering Gd-Labeled IgG Antibodies Into the Mouse Brain Following Focused Ultrasound Treatment.
PubMed 文献 · Ultrasound Med Biol · 2025-03-13

本研究旨在用MRI确认聚焦超声联合循环微泡后Gd标记IgG抗体递送至小鼠脑内。先在体模中量化9.4 T和3 T下Gd-IgG信号,再确定超声与MRI参数以可逆开放血脑屏障并监测递送。结果证实抗体可可靠递送并可用临床相关序列追踪,最大递送体积0.12±0.02 mm3(n=4,治疗后75.3±17.3分钟)。

要点

  • 聚焦超声联合微泡可非侵入、局部、可逆开放小鼠血脑屏障并递送Gd-IgG抗体。
  • 临床相关MRI序列可追踪Gd-IgG抗体在脑实质内的分布。
  • 最大递送体积0.12±0.02 mm3(n=4),于治疗后75.3±17.3分钟测得。

核心结论

  • 聚焦超声联合微泡可将Gd标记IgG抗体可靠递送至小鼠脑内,并可用临床相关MRI序列追踪其在脑实质内的生物分布;该工作为可扩展、非电离的抗体递送方法及评估铺路。

研究设计与样本

  • 临床前研究:先用临床前9.4 T与临床3 T MRI扫描仪在体模中量化Gd标记IgG抗体的MR信号,再确定超声与MR成像参数,以非侵入、安全、局部、可逆方式破坏小鼠血脑屏障并监测抗体递送。

诊断标准与关键数值

  • 最大检测到的Gd-IgG抗体递送体积为0.12±0.02 mm3(n=4),于治疗后t=75.3±17.3分钟测得。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Antibody-based therapy has emerged as a powerful tool for targeted treatment of neurological diseases, such as brain cancer and neurodegenerative disorders. However, direct, scalable, and safe confirmation of antibody delivery into the brain remains challenging. Antibodies can be effectively tracked when tagged with molecules that are detectable by medical imaging modalities, such as MRI, PET, or SPECT. In this study, we aimed to confirm gadolinium (Gd)-labeled IgG antibody delivery into the mouse brain using MRI, following exposure to focused ultrasound (FUS) and circulating microbubbles.

METHODS: We acquired MR images of the mouse brain to evaluate antibody delivery into the targeted brain region. First, we quantified the MR signal of Gd-labeled IgG antibodies in phantoms using preclinical 9.4 T and clinical 3 T MRI scanners. Then, we determined optimal ultrasound and MR imaging parameters to non-invasively and safely disrupt the blood-brain barrier in a localized and reversible manner and effectively monitor antibody delivery into the murine brain, respectively.

RESULTS: We confirmed that IgG antibodies can be reliably delivered into the murine brain using FUS and microbubble treatment and that we can track their biodistribution within the brain parenchyma using clinically relevant MR image sequences. The maximum detected volume of Gd-IgG antibody delivery (n = 4) was determined to be 0.12 ± 0.02 mm3 at t = 75.3 ± 17.3 minutes following treatment.

CONCLUSION: This work paves the way for a scalable and non-ionizing method for performing and evaluating antibody delivery into the brain.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Koruk H, Payne C, Cressey P, et al. Delivering Gd-Labeled IgG Antibodies Into the Mouse Brain Following Focused Ultrasound Treatment. Ultrasound Med Biol. 2025. PMID: 40087107. doi:10.1016/j.ultrasmedbio.2025.02.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。